Weekly Cumulative RSV Vaccination Coverage and Intent, Overall, by Selected Demographics and Jurisdiction, Among Adults 75 and Older and 60-74 Years with High-Risk Conditions Ever Vaccinated, United States
• Weekly Cumulative RSV Vaccination Coverage and Intent Among Adults 75 Years and Older and 60─74 Years with High Risk Conditions Ever Vaccinated with RSV Vaccine by Demographic Characteristics and Jurisdiction
• Weekly estimates of RSV vaccination coverage and intent among adults 75 years and older and 60─74 years with high risk conditions are calculated using data from the National Immunization Survey–Adult COVID Module (NIS–ACM) (https://www.cdc.gov/nis/about/index.html).
• In June 2023, the Advisory Committee on Immunization Practices (ACIP) voted to recommend that adults aged ≥60 years may receive a single dose of an RSV vaccine, using shared clinical decision-making. In June 2024, the ACIP voted to recommend a single dose of RSV vaccine for all adults 75 years and older and adults 60–74 years who are at increased risk for severe RSV disease. The data below captures ever receiving a dose of an RSV vaccine by adults 60 years and older.
Resources
3 resources available
-
Resource 1
TEXT/CSV -
Resource 2
APPLICATION/JSON -
Resource 3
APPLICATION/XML
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| bureauCode |
[ "009:20" ] |
| contactPoint |
{ "fn": "VaxView Team", "@type": "vcard:Contact", "hasEmail": "mailto:VaxView@cdc.gov" } |
| description | • Weekly Cumulative RSV Vaccination Coverage and Intent Among Adults 75 Years and Older and 60─74 Years with High Risk Conditions Ever Vaccinated with RSV Vaccine by Demographic Characteristics and Jurisdiction • Weekly estimates of RSV vaccination coverage and intent among adults 75 years and older and 60─74 years with high risk conditions are calculated using data from the National Immunization Survey–Adult COVID Module (NIS–ACM) (https://www.cdc.gov/nis/about/index.html). • In June 2023, the Advisory Committee on Immunization Practices (ACIP) voted to recommend that adults aged ≥60 years may receive a single dose of an RSV vaccine, using shared clinical decision-making. In June 2024, the ACIP voted to recommend a single dose of RSV vaccine for all adults 75 years and older and adults 60–74 years who are at increased risk for severe RSV disease. The data below captures ever receiving a dose of an RSV vaccine by adults 60 years and older. |
| distribution |
[ { "@type": "dcat:Distribution", "mediaType": "text/csv", "downloadURL": "https://data.cdc.gov/api/v3/views/k4cb-dxd7/export.csv?accessType=DOWNLOAD" }, { "@type": "dcat:Distribution", "mediaType": "application/json", "downloadURL": "https://data.cdc.gov/api/v3/views/k4cb-dxd7/query.json?accessType=DOWNLOAD" }, { "@type": "dcat:Distribution", "mediaType": "application/xml", "downloadURL": "https://data.cdc.gov/api/v3/views/k4cb-dxd7/query.xml?accessType=DOWNLOAD" } ] |
| identifier | https://data.cdc.gov/api/views/k4cb-dxd7 |
| issued | 2025-05-20 |
| keyword |
[ "iis", "iqvia", "nis-acm", "nis-flu", "rsv vaccination", "vsd" ] |
| landingPage | https://www.cdc.gov/rsvvaxview/ |
| language |
[ "English" ] |
| license | https://www.usa.gov/government-works |
| modified | 2026-08-03 |
| programCode |
[ "009:020" ] |
| publisher |
{ "name": "Centers for Disease Control and Prevention", "@type": "org:Organization" } |
| spatial | United States |
| theme |
[ "Vaccinations" ] |
| title | Weekly Cumulative RSV Vaccination Coverage and Intent, Overall, by Selected Demographics and Jurisdiction, Among Adults 75 and Older and 60-74 Years with High-Risk Conditions Ever Vaccinated, United States |
